EV Biologics (EV Biologics) Other Net Income (Loss) : $-0.00 Mil (TTM As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Other Net Income (Loss)?

EV Biologics's Other Net Income (Loss) for the three months ended in Dec. 2017 was $-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.00 Mil.

EV Biologics's quarterly Other Net Income (Loss) stayed the same from Dec. 2016 ($0.00 Mil) to Jun. 2017 ($0.00 Mil) but then declined from Jun. 2017 ($0.00 Mil) to Dec. 2017 ($-0.00 Mil).

EV Biologics's annual Other Net Income (Loss) stayed the same from Jun. 2015 ($0.00 Mil) to Jun. 2016 ($0.00 Mil) but then increased from Jun. 2016 ($0.00 Mil) to Jun. 2017 ($0.00 Mil).

EV Biologics Other Net Income (Loss) Historical Data

The historical data trend for EV Biologics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Other Net Income (Loss) Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Other Net Income (Loss)

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Other Net Income (Loss)	Get a 7-Day Free Trial												-	-	-	-	-

EV Biologics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

EV Biologics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of EV Biologics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Other Net Income (Loss)

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3